Home/Filings/4/0001127602-25-016497
4//SEC Filing

Basil Michelle L 4

Accession 0001127602-25-016497

CIK 0000313143other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:31 PM ET

Size

6.6 KB

Accession

0001127602-25-016497

Insider Transaction Report

Form 4
Period: 2025-05-30
Basil Michelle L
EVP and General Counsel
Transactions
  • Award

    Common Stock

    2025-05-30+15,55449,721 total
  • Tax Payment

    Common Stock

    2025-05-30$69.38/sh7,469$518,19942,252 total
Footnotes (3)
  • [F1]Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on May 16, 2022, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 16, 2022 to May 15, 2025, as certified by the Compensation Committee of the Board of Directors on May 30, 2025.
  • [F2]This number includes unvested restricted stock units ("RSUs") previously reported.
  • [F3]Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I.

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1
  • filerCIK 0001699629

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:31 PM ET
Size
6.6 KB